Sg Americas Securities, LLC Athenex, Inc. Transaction History

Sg Americas Securities, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$0.79 - $1.59 $14,949 - $30,087	-18,923 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$1.36 - $2.94 $37,729 - $81,561	-27,742 Reduced 59.45%	18,923 $26,000
Q3 2021 Nov 01, 2021	BUY	$2.97 - $4.84 $138,595 - $225,858	46,665 New	46,665 $140,000
Q2 2021 Aug 12, 2021	SELL	$3.71 - $5.13 $64,494 - $89,179	-17,384 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$4.08 - $14.75 $11,207 - $40,518	2,747 Added 18.77%	17,384 $75,000
Q4 2020 Feb 04, 2021	BUY	$11.06 - $14.01 $58,783 - $74,463	5,315 Added 57.02%	14,637 $162,000
Q3 2020 Nov 09, 2020	SELL	$10.26 - $14.55 $257,823 - $365,626	-25,129 Reduced 72.94%	9,322 $113,000
Q2 2020 Jul 20, 2020	SELL	$7.11 - $13.76 $84,616 - $163,757	-11,901 Reduced 25.68%	34,451 $474,000
Q1 2020 Apr 30, 2020	BUY	$5.71 - $15.85 $126,784 - $351,933	22,204 Added 91.95%	46,352 $359,000
Q4 2019 Jan 28, 2020	BUY	$9.6 - $17.75 $231,820 - $428,627	24,148 New	24,148 $369,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.